SITE012-0172

SITE012 (BRA) › SITE012-0172

SITE012-0172

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2026-03-28

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-03-04 (study day 154); relationship: not assessed

mild assessed

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-18 (study day 140); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.